Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.92124 | 39 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.90123 | 39 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.91656 | 40 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.95639 | 44 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.85682 | 40 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.93349 | 37 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.95428 | 39 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.88496 | 39 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.88061 | 39 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.90133 | 40 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.8897 | 39 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.88144 | 40 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.89087 | 39 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.89789 | 39 |